Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2011;13(5):129.
doi: 10.1186/ar3472. Epub 2011 Oct 7.

Use of administrative claims data for comparative effectiveness research of rheumatoid arthritis treatments

Seo Young Kim, Daniel H Solomon
Editorial

Use of administrative claims data for comparative effectiveness research of rheumatoid arthritis treatments

Seo Young Kim et al. Arthritis Res Ther. 2011.

Abstract

Observational studies, particularly those using large administrative claims databases, have become increasingly popular sources of comparative effectiveness or comparative safety research. Studies using claims data often face challenges and criticisms due to the lack of certain clinical information, such as lifestyle risk factors, disease severity, and questionable accuracy of disease diagnoses. A novel, claims-based algorithm to evaluate the clinical effectiveness of rheumatoid arthritis medications has been developed and its performance seems promising, although further validation is needed.

PubMed Disclaimer

Comment on

References

    1. Curtis JR, Baddley JW, Yang S, Patkar N, Chen L, Delzell E, Mikuls TR, Saag KG, Singh J, Safford M, Cannon GW. Derivation and preliminary validation of an administrative claims-based algorithm for the effectiveness of medications for rheumatoid arthritis. Arthritis Res Ther. 2011;13:R155. doi: 10.1186/ar3471. - DOI - PMC - PubMed
    1. Institute of Medicine. Initial National Priorities for Comparative Effectiveness Research. Washington, DC: Institute of Medicine; 2009.
    1. Curtis JR, Jain A, Askling J, Bridges SL Jr, Carmona L, Dixon W, Finckh A, Hyrich K, Greenberg JD, Kremer J, Listing J, Michaud K, Mikuls T, Shadick N, Solomon DH, Weinblatt ME, Wolfe F, Zink A. A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries. Semin Arthritis Rheum. 2010;40:2–14. doi: 10.1016/j.semarthrit.2010.03.003. - DOI - PMC - PubMed
    1. Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol. 2005;58:323–327. doi: 10.1016/j.jclinepi.2004.10.012. - DOI - PubMed
    1. Kim S, Servi A, Polinski J, Mogun H, Weinblatt M, Katz J, Solomon DH. Validation of rheumatoid arthritis diagnoses in health care utilization data. Arthritis Res Ther. 2011;13:R32. doi: 10.1186/ar3260. - DOI - PMC - PubMed

MeSH terms

Substances